The study, published in Nature Health, examined how medical AI research incorporated four broad categories of patient factors: perceived usability and feasibility, trust and safety, acceptance and perception, and adherence. These dimensions describe how patients understand AI-enabled care and how they respond to it in practice. Usability concerns whether a patient can navigate an AI-supported service or make sense of its outputs. Trust involves confidence in the technology, the clinicians using it and the institutions responsible for it. Safety includes not only whether an algorithm makes technically incorrect predictions, but also whether its use creates new risks, such as delayed treatment, inappropriate reassurance, privacy loss or unequal performance across patient groups. Acceptance and adherence capture whether patients are willing to engage with AI-supported care and follow recommendations generated through it. Together, these factors determine whether a technically capable system becomes a useful clinical intervention or remains an impressive but poorly adopted prototype.

The review found a striking imbalance in what researchers chose to measure. Patient satisfaction appeared in 70.6 per cent of the papers, while perceived benefits were reported in 69.4 per cent. These measures can provide valuable information, but they are often broad and subjective. A patient may report that an AI tool is convenient or beneficial without understanding how its prediction was produced, what data were used or what limitations apply. Satisfaction can also be shaped by short-term novelty, reduced waiting times or enthusiasm for new technology rather than by long-term safety and effectiveness. By contrast, foundational questions were much less common. Trust was examined in only 16.7 per cent of the studies, and safety in 10.9 per cent. The pattern suggests that research has concentrated on whether patients like an AI system, while giving less attention to whether they can rely on it, question it and remain protected when it fails.

This distinction is crucial because medical AI does not operate in a vacuum. Most systems transform patient information—such as medical images, laboratory results, electronic health records, physiological signals or responses to questionnaires—into a probability, classification or recommendation. The output may be statistically accurate at the population level but still uncertain for an individual. A diagnostic model, for example, might estimate the probability that a scan contains a tumour, while a risk-prediction system might calculate the likelihood of hospitalisation within a specified period. Such outputs are not self-explanatory facts; they are model-dependent estimates affected by the quality of the input data, the population on which the model was trained and the clinical setting in which it is deployed. If patients are not told how much uncertainty surrounds a recommendation, they may over-trust an automated result or reject it altogether. Both responses can undermine care.

The timing of patient involvement was even more uneven than the selection of factors. The review reported that 89.4 per cent of assessments across the AI lifecycle occurred during the validation phase, when a system is tested to determine whether it works under defined conditions. Only 3.9 per cent involved patient factors during design and development. The AI lifecycle generally includes problem definition and design, data collection and model development, clinical validation, deployment and subsequent monitoring. By the time validation begins, many fundamental choices have already been made: which clinical problem to target, whose data to include, what outcome to predict, how results will be displayed and which users will be responsible for acting on them. Late-stage feedback can identify usability problems, but it may be unable to repair assumptions embedded in the system from the start.

Early participation could expose problems that technical testing alone cannot detect. Patients may question whether a proposed AI application addresses a meaningful clinical need, whether the information it requires is proportionate or whether its benefits justify the risks. They may identify cultural, linguistic, economic or accessibility barriers that researchers have overlooked. A remote monitoring system that appears straightforward to developers may be unusable for people without reliable internet access, limited digital literacy or disabilities that affect interaction with a device. An automated risk score may also rely on variables that patients consider sensitive or inappropriate, particularly when they do not know how those variables influence the prediction. These are not merely communication issues to be fixed with a user manual. They can alter who benefits from the technology, who is excluded and how clinical decisions are made.

Trust, meanwhile, is not equivalent to believing that an algorithm is accurate. It is a relationship involving patients, clinicians, developers and healthcare institutions. Patients may trust an AI recommendation when a doctor explains its rationale, acknowledges its uncertainty and remains accountable for the final decision. They may distrust the same recommendation if it appears to replace professional judgment or if no one can explain how to contest an error. Trust can also be damaged by the wider history of medical data use, including concerns about surveillance, commercial exploitation and breaches of confidentiality. A system trained on large datasets must therefore be evaluated not only for predictive performance but also for governance: who controls the data, who audits the model, who is responsible when it fails and how patients are informed about automated processing.

Safety presents a similarly broad challenge. Conventional validation may compare an algorithm’s predictions with a reference standard, such as a diagnosis confirmed by specialists or a later clinical outcome. Yet safe deployment requires examining the entire chain from data collection to human action. A model can be accurate in isolation but unsafe if clinicians misinterpret its output, if alerts are so frequent that they are ignored, or if the system performs poorly after patient demographics, equipment or clinical practices change. Safety also requires attention to subgroup performance. If an algorithm has been developed predominantly using data from one population, its error rates may differ for patients of other ages, ethnic backgrounds, sexes, socioeconomic circumstances or disease profiles. Patients need meaningful information about these limitations, while institutions need procedures for detecting drift and withdrawing systems that no longer perform as intended.

The authors’ central message is not that medical AI should be abandoned, but that patient factors must move from the margins to the centre of its development. Future studies could combine technical metrics with structured measures of trust, perceived safety, comprehension, autonomy, accessibility and adherence, following patients over time rather than surveying them once after a trial. Researchers could involve patients in defining research questions, selecting outcomes, designing interfaces and interpreting failures. Clinical validation could assess not just whether a model predicts accurately, but whether its use changes decisions, improves outcomes and avoids harmful disparities in ordinary care. Continuous monitoring after deployment would be equally important because real-world populations and clinical workflows evolve. As AI systems become more visible in diagnosis, screening, monitoring and treatment, the most persuasive measure of progress may not be how powerful a model is on a benchmark, but whether patients can understand its role, participate in decisions and remain safe when the technology is wrong. The review makes clear that the future of medical AI will be shaped as much by human confidence and accountability as by computational performance.

Subject of Research: Patient factors in medical artificial intelligence research, including usability, trust, safety, acceptance, perception and adherence across the AI lifecycle

Article Title: Patient factors in medical artificial intelligence: a systematic review

Article References: Lai, S., Guan, Z., Zhang, Y. et al. “Patient factors in medical artificial intelligence: a systematic review.” Nature Health (2026). https://doi.org/10.1038/s44360-026-00190-2

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s44360-026-00190-2

Keywords: medical artificial intelligence, patient trust, AI safety, clinical validation, healthcare technology, patient acceptance, AI usability, medical ethics

Ambient listening scribe technology operates as a sophisticated tool designed to capture physician-patient conversations in real time, transcribing them accurately and seamlessly. By integrating voice recognition software with natural language processing algorithms, this technology is capable of generating patient notes without disrupting the flow of dialogue. This not only promises improved documentation accuracy but also enhances the overall patient experience, fostering a more interactive and engaging environment during consultations.

One of the core objectives of the study was to assess the performance of this technology in real-world outpatient contexts. The researchers conducted a mixed methods trial evaluation, involving quantitative data analysis along with qualitative insights. These comprehensive insights allowed for a nuanced understanding of how ambient listening scribe technology performs under varying circumstances and environments. The findings suggest that the technology maintained a high transcription accuracy, often exceeding traditional documentation methods.

Moreover, patient and provider feedback was collected to gauge the acceptability of the ambient listening scribe. Many participants reported a significant reduction in the administrative burden previously placed on healthcare professionals, enabling them to dedicate more attention to their patients. The feedback highlighted that both patients and providers felt more connected during their interactions, as the technology minimized interruptions that were once commonplace due to note-taking requirements.

Diving deeper into the technology’s impact, the study revealed that ambient listening scribe technology could also lead to a reduction in consultation times. With healthcare providers no longer tethered to manual note-taking, appointments could maintain a steady rhythm, facilitating a more thorough exchange of information within a shorter timeframe. This efficiency could potentially lead to an increased patient turnover rate in outpatient settings without sacrificing the quality of care delivered.

Engagement with ambient listening scribe technology has shown promise in improving patient satisfaction scores. Patients appreciated the undivided attention from their healthcare providers, which, in turn, fostered a more trusting and open dialogue about their health conditions. The ability of providers to respond in real-time to patient concerns, without the distraction of administrative tasks, reinforced the quality of the patient experience.

However, the study did not shy away from addressing potential challenges associated with the implementation of such technology. Among the concerns raised were issues related to privacy and data security. It is essential for healthcare organizations to assure both providers and patients that necessary safeguards are in place to protect sensitive health information, especially as ambient listening capabilities involve recording personal conversations. This highlights the need for robust regulatory frameworks and ethical guidelines as the technology becomes more widely adopted.

Additionally, some healthcare providers expressed initial skepticism regarding the effectiveness of the technology, particularly in busy outpatient settings where interruptions might be frequent. Yet, the study’s findings indicated that once trained on the system, providers became advocates for its integration, recognizing its significant benefits in reducing paperwork and improving workflow efficiency.

Training and integration were highlighted as pivotal components for successful implementation. Healthcare teams underwent thorough training sessions to familiarize themselves with the technology’s functionalities. This ensured that providers were confident in utilizing the scribe effectively, which contributed to the overall positive reception of the technology. Continuous support and feedback mechanisms were also crucial in addressing any ongoing concerns or adjustments needed in the system.

As healthcare continues to evolve alongside technological advancements, the implications of ambient listening scribe technology extend beyond mere administrative efficiencies. This research underpins a paradigm shift in how care is delivered, emphasizing the importance of patient-centered approaches that prioritize communication and connection. The results advocates for a future where technology serves as a partner in healthcare delivery, rather than a distraction from it.

It’s evident that the fusion of technology within healthcare ultimately aims to enhance not just operational metrics but also the human experience. By embracing tools like ambient listening scribe technology, healthcare providers can shed the encumbrance of excess documentation, reclaim their roles as caregivers, and focus on what truly matters—delivering quality health services to patients.

In conclusion, the mixed methods trial evaluation led by Memon et al. provides compelling evidence supporting the integration of ambient listening scribe technology in outpatient settings. It opens avenues for further research and development, particularly around enhancing the technology, addressing privacy concerns, and optimizing workflows. As this technology matures, it promises a more dynamic, efficient, and humane approach to healthcare, thereby transforming the landscape of outpatient services.

In summary, the potential benefits of ambient listening scribe technology align with the broader trend towards digitization and improved patient experiences in healthcare. As the industry grapples with the ongoing challenges of high workloads and stringent documentation requirements, the findings from this study herald a future where healthcare delivery can seamlessly blend the human touch with technological proficiency.

Subject of Research: Ambient Listening Scribe Technology

Article Title: Performance, acceptability, and impact of ambient listening scribe technology in an outpatient context: a mixed methods trial evaluation.

Article References:

Memon, S., Brand, A., Taylor, B. et al. Performance, acceptability, and impact of ambient listening scribe technology in an outpatient context: a mixed methods trial evaluation. BMC Health Serv Res (2026). https://doi.org/10.1186/s12913-025-13954-5

Image Credits: AI Generated

DOI:

Keywords: Ambient listening, Scribe technology, Outpatient care, Healthcare efficiency, Patient experience.